These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 21836478

  • 1. Pax8 expression in thymic epithelial neoplasms: an immunohistochemical analysis.
    Weissferdt A, Moran CA.
    Am J Surg Pathol; 2011 Sep; 35(9):1305-10. PubMed ID: 21836478
    [Abstract] [Full Text] [Related]

  • 2. A comprehensive analysis of PAX8 expression in human epithelial tumors.
    Laury AR, Perets R, Piao H, Krane JF, Barletta JA, French C, Chirieac LR, Lis R, Loda M, Hornick JL, Drapkin R, Hirsch MS.
    Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115
    [Abstract] [Full Text] [Related]

  • 3. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.
    Kim DJ, Yang WI, Kim SH, Park IK, Chung KY.
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):611-6. PubMed ID: 16125946
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
    Su XY, Wang WY, Li JN, Liao DY, Wu WL, Li GD.
    Int J Clin Exp Pathol; 2015 Oct; 8(5):5354-62. PubMed ID: 26191237
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms.
    Kojika M, Ishii G, Yoshida J, Nishimura M, Hishida T, Ota SJ, Murata Y, Nagai K, Ochiai A.
    Mod Pathol; 2009 Oct; 22(10):1341-50. PubMed ID: 19648882
    [Abstract] [Full Text] [Related]

  • 6. PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison.
    Ozcan A, Liles N, Coffey D, Shen SS, Truong LD.
    Am J Surg Pathol; 2011 Dec; 35(12):1837-47. PubMed ID: 21989345
    [Abstract] [Full Text] [Related]

  • 7. PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody.
    Hu Y, Hartmann A, Stoehr C, Zhang S, Wang M, Tacha D, Montironi R, Lopez-Beltran A, Cheng L.
    J Clin Pathol; 2012 Mar; 65(3):254-6. PubMed ID: 22135028
    [Abstract] [Full Text] [Related]

  • 8. Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1.
    Weissferdt A, Tang X, Wistuba II, Moran CA.
    Mod Pathol; 2013 Dec; 26(12):1554-60. PubMed ID: 23787439
    [Abstract] [Full Text] [Related]

  • 9. Expression of proteasome subunit β5t in thymic epithelial tumors.
    Yamada Y, Tomaru U, Ishizu A, Kiuchi T, Marukawa K, Matsuno Y, Kasahara M.
    Am J Surg Pathol; 2011 Sep; 35(9):1296-304. PubMed ID: 21836487
    [Abstract] [Full Text] [Related]

  • 10. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
    Thomas de Montpréville V, Quilhot P, Chalabreysse L, De Muret A, Hofman V, Lantuéjoul S, Parrens M, Payan MJ, Rouquette I, Secq V, Girard N, Besse B, Marx A, Molina TJ.
    Pathol Res Pract; 2015 Dec; 211(12):996-1002. PubMed ID: 26534878
    [Abstract] [Full Text] [Related]

  • 11. Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems.
    Ma Y, Li Q, Cui W, Miao N, Liu X, Zhang W, Zhang C, Wang J.
    Diagn Pathol; 2012 Sep 14; 7():120. PubMed ID: 22974165
    [Abstract] [Full Text] [Related]

  • 12. Multilocular thymic cyst associated with thymoma: a clinicopathologic study of 20 cases with an emphasis on the pathogenesis of cyst formation.
    Nakamura S, Tateyama H, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Mizuno T, Ishiguro F, Yokoi K.
    Am J Surg Pathol; 2012 Dec 14; 36(12):1857-64. PubMed ID: 23026930
    [Abstract] [Full Text] [Related]

  • 13. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.
    Pfister F, Hussain H, Belharazem D, Busch S, Simon-Keller K, Becker D, Pfister E, Rieker R, Ströbel P, Marx A.
    Histopathology; 2017 Apr 14; 70(5):693-703. PubMed ID: 27791295
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas.
    Roden AC, Yi ES, Jenkins SM, Donovan JL, Cassivi SD, Garces YI, Marks RS, Aubry MC.
    Hum Pathol; 2015 Jan 14; 46(1):17-25. PubMed ID: 25455993
    [Abstract] [Full Text] [Related]

  • 15. Cytokeratins in normal thymus and thymic epithelial tumors.
    Fukai I, Masaoka A, Hashimoto T, Yamakawa Y, Mizuno T, Tanamura O.
    Cancer; 1993 Jan 01; 71(1):99-105. PubMed ID: 7677978
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.
    Nakagawa K, Matsuno Y, Kunitoh H, Maeshima A, Asamura H, Tsuchiya R.
    Chest; 2005 Jul 01; 128(1):140-4. PubMed ID: 16002927
    [Abstract] [Full Text] [Related]

  • 17. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
    Pan CC, Chen PC, Chou TY, Chiang H.
    Hum Pathol; 2003 Nov 01; 34(11):1155-62. PubMed ID: 14652817
    [Abstract] [Full Text] [Related]

  • 18. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting.
    Marx A, Ströbel P, Badve SS, Chalabreysse L, Chan JK, Chen G, de Leval L, Detterbeck F, Girard N, Huang J, Kurrer MO, Lauriola L, Marino M, Matsuno Y, Molina TJ, Mukai K, Nicholson AG, Nonaka D, Rieker R, Rosai J, Ruffini E, Travis WD.
    J Thorac Oncol; 2014 May 01; 9(5):596-611. PubMed ID: 24722150
    [Abstract] [Full Text] [Related]

  • 19. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
    Nonaka D, Chiriboga L, Soslow RA.
    Am J Surg Pathol; 2008 Oct 01; 32(10):1566-71. PubMed ID: 18724243
    [Abstract] [Full Text] [Related]

  • 20. Utility of monoclonal PAX8 antibody for distinguishing intrathyroid thymic carcinoma from follicular cell-derived thyroid carcinoma.
    Suzuki A, Hirokawa M, Takada N, Higuchi M, Tanaka A, Hayashi T, Kuma S, Miyauchi A.
    Endocr J; 2018 Dec 28; 65(12):1171-1175. PubMed ID: 30210064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.